Takeda Oncology's research and development approach focuses on leveraging the power of innate immunity to advance cutting-edge immunotherapies for cancer treatment. Learn more about our scientific platforms and collaborations aimed at producing deep, durable responses in patients with solid tumors and blood cancers. Explore our commitment to harnessing the immune system to fight cancer. 

Takeda Oncology's R&D Approach: Advancing Immuno-Oncology through Innate Immunity | Takeda Oncology

Science

# Science and Research

## Learn More About Our Science and Research

### Our Scientific Platforms

/science/scientific-platforms/

### Pipeline

/science/pipeline/

### Clinical Trials

/science/clinical-trials/

Cancel

You are now leaving Takedaoncology.com and entering a website that is not owned or controlled by Takeda. 

Takeda Oncology makes no representation as to the accuracy of the information contained on websites we do not own or control. Takeda Oncology does not recommend or endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.
